PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
07-May-2024 Fresenius SE & Co. KGaA: Fresenius raises outlook for fiscal year 2024 Fresenius SE & Co. KGaA
07-May-2024 Biotest AG: Annual General Meeting approves dividend distribution Biotest AG
07-May-2024 Medacta announces the results of today's Annual General Meeting Medacta Group SA
07-May-2024 Annual General Meeting of SKAN Group AG approves all pro-posals and elects Beat Lüthi as Chairman SKAN AG
07-May-2024 Moberg Pharma´s interim report January - March 2024 Moberg Pharma
07-May-2024 M1 Kliniken AG: Supervisory Board approves 2023 annual financial statements. Dividend proposal of EUR 0.50 per share M1 Kliniken AG
07-May-2024 MPH Health Care AG: Supervisory Board adopts the 2023 annual financial statements. Dividend proposal of EUR 1.20 per share MPH Health Care AG
07-May-2024 Mainz Biomed to Present Results of Colorectal Cancer Screening Study eAArly DETECT at Digestive Disease Week 2024 in Washington, D.C. Mainz BioMed N.V.
07-May-2024 Formycon invites to the Annual General Meeting on June 12, 2024 in Munich Formycon AG
07-May-2024 Atopia Therapeutics, Formerly HpVac, Announces Appointment of Dr. Gregoire Chevalier as CEO and Business Update Atopia Therapeutics
07-May-2024 Biotest increased sales by 83.6% to Euro 215.2 million in first quarter 2024 Biotest AG
07-May-2024 Medios AG records further revenue growth in the first quarter of 2024 and confirms full-year guidance Medios AG
06-May-2024 Medios AG: Constantijn van Rietschoten appointed Executive Board member for International Markets Medios AG
06-May-2024 DocMorris announces the start of the tender offer period for its Outstanding Convertible Bonds due 2025 DocMorris AG
03-May-2024 NEW COMMERCIAL AGREEMENT WITH LARGE PHARMA ANGLE plc
03-May-2024 Kancera meets the primary objectives of the KAND145 clinical phase I study Kancera AB
02-May-2024 Poolbeg Pharma plc - Significant POLB 001 Patent Granted in United States Poolbeg Pharma plc
02-May-2024 Resolutions of the 31st Annual General Meeting of DocMorris AG of 2 May 2024 in Zurich DocMorris AG
02-May-2024 MEDICLIN: Transfer of operations of Reha-Klinik am Sendesaal to MEDICLIN took place on 1 May MEDICLIN AG
02-May-2024 MEDICLIN increases consolidated sales and operating result in the first quarter of 2024 MEDICLIN AG